ENIMMUNE CORPORATI financial statements, including revenue, expenses, profit, and loss

The total revenue of 6564 for the last semiannual is 30.49 M TWD, and it's 134.57% higher compared to the previous semiannual. The net income of H2 23 is -146.03 M TWD.